Annual Cash & Cash Equivalents
$9.63 B
-$4.03 B-29.51%
31 December 2023
Summary:
Sanofi annual cash & cash equivalents is currently $9.63 billion, with the most recent change of -$4.03 billion (-29.51%) on 31 December 2023. During the last 3 years, it has fallen by -$7.49 billion (-43.74%). SNY annual cash & cash equivalents is now -43.74% below its all-time high of $17.11 billion, reached on 31 December 2020.SNY Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
N/A
01 September 2024
Summary:
Sanofi quarterly cash and cash equivalents is not available.SNY Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SNY Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.5% | - |
| 3 y3 years | -43.7% | - |
| 5 y5 years | +21.5% | - |
SNY Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -43.7% | at low | ||
| 5 y | 5 years | -43.7% | +21.5% | ||
| alltime | all time | -43.7% | +8699.1% |
Sanofi Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $7.28 B(-24.4%) |
| Dec 2023 | $9.63 B(-29.5%) | $9.63 B(+10.8%) |
| June 2023 | - | $8.69 B(-36.4%) |
| Dec 2022 | $13.66 B(+19.5%) | $13.66 B(+89.5%) |
| June 2022 | - | $7.21 B(-37.0%) |
| Dec 2021 | $11.43 B(-33.2%) | $11.43 B(-1.2%) |
| June 2021 | - | $11.57 B(-35.6%) |
| Dec 2020 | $17.11 B(+62.1%) | - |
| June 2020 | - | $17.96 B(+70.1%) |
| Dec 2019 | $10.56 B(+33.3%) | $10.56 B(+37.8%) |
| June 2019 | - | $7.67 B(-3.2%) |
| Dec 2018 | $7.92 B(-36.0%) | $7.92 B(-8.6%) |
| June 2018 | - | $8.66 B(-30.0%) |
| Dec 2017 | $12.37 B(+13.9%) | $12.37 B(+13.9%) |
| Dec 2016 | $10.86 B(+8.6%) | $10.86 B(+8.6%) |
| Dec 2015 | $10.00 B(+12.0%) | $10.00 B(+89.7%) |
| June 2015 | - | $5.27 B(-40.9%) |
| Dec 2014 | $8.93 B(-21.7%) | $8.93 B(+52.0%) |
| June 2014 | - | $5.87 B(-48.5%) |
| Dec 2013 | $11.40 B(+35.1%) | $11.40 B(+109.2%) |
| June 2013 | - | $5.45 B(-35.4%) |
| Dec 2012 | $8.44 B(+58.0%) | $8.44 B(+57.5%) |
| June 2012 | - | $5.36 B(+0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $5.34 B(-37.9%) | $5.34 B(-43.6%) |
| June 2011 | - | $9.47 B(+10.1%) |
| Dec 2010 | $8.60 B(+28.1%) | $8.60 B(+118.3%) |
| June 2010 | - | $3.94 B(-41.3%) |
| Dec 2009 | $6.71 B(+13.6%) | $6.71 B(-23.1%) |
| June 2009 | - | $8.72 B(+47.7%) |
| Dec 2008 | $5.91 B(+136.5%) | $5.91 B(+296.1%) |
| June 2008 | - | $1.49 B(-40.3%) |
| Dec 2007 | $2.50 B(+64.1%) | $2.50 B(+70.4%) |
| June 2007 | - | $1.47 B(-3.7%) |
| Dec 2006 | $1.52 B(+3.0%) | $1.52 B(+2.5%) |
| June 2006 | - | $1.48 B(+0.5%) |
| Dec 2005 | $1.48 B(-40.7%) | $1.48 B(-45.9%) |
| June 2005 | - | $2.73 B(+9.5%) |
| Dec 2004 | $2.49 B(+1206.2%) | $2.49 B(+1431.8%) |
| June 2004 | - | $162.77 M(-14.7%) |
| Dec 2003 | $190.88 M(+26.5%) | $190.88 M(+53.7%) |
| June 2003 | - | $124.16 M(-17.7%) |
| Dec 2002 | $150.95 M(+38.0%) | $150.95 M(-20.9%) |
| June 2002 | - | $190.88 M |
| Dec 2001 | $109.42 M(-43.7%) | - |
| Dec 2000 | $194.41 M(-4.2%) | - |
| Dec 1999 | $203.03 M | - |
FAQ
- What is Sanofi annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Sanofi?
- What is Sanofi annual cash & cash equivalents year-on-year change?
- What is the all time high quarterly cash and cash equivalents for Sanofi?
What is Sanofi annual cash & cash equivalents?
The current annual cash & cash equivalents of SNY is $9.63 B
What is the all time high annual cash & cash equivalents for Sanofi?
Sanofi all-time high annual cash & cash equivalents is $17.11 B
What is Sanofi annual cash & cash equivalents year-on-year change?
Over the past year, SNY annual cash & cash equivalents has changed by -$4.03 B (-29.51%)
What is the all time high quarterly cash and cash equivalents for Sanofi?
Sanofi all-time high quarterly cash and cash equivalents is $17.96 B